Infinity Pharmaceuticals, Inc. (NASDAQ:INFI)
CAPS Rating:
The Company's mission is to discover, develop, and deliver to patients medicines for the treatment of cancer and related conditions.
Get rich slowly
The Company's mission is to discover, develop, and deliver to patients medicines for the treatment of cancer and related conditions.
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates, Analyst Ratings and Key Statistics provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions
RSS Headlines
Fool UK
Recs
Not much inspiring news to report from the world of Infinity. So far retaspimycin has shown uninspiring results in GIST and now lung cancer. But with their substantial cash reserves and controlled burn rate I'm still willing to give them the benefit of the doubt, hoping for better data from the breast cancer trial in the near future. I'm also happy that they've broadened their pipeline by moving IPI-493 Hsp90 chaperone inhibitor into clinical trials.